首页>外文期刊>医学、药学、卫生>临床医学>Therapeutic advances in medical oncology.

Therapeutic advances in medical oncology.

中文名称：医学肿瘤学的治疗进展。

ISSN：1758-8340
出版周期：Bimonthly

发文量：565

期刊论文

热门论文

年度选择

2020
- 第12期
2019
- 第11期
- 第12期
2018
- 第3期
- 第6期
- 第10期
- 第12期
2017
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2016
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2015
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2014
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2013
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2012
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
2011
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第1asuppl期
2010
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期

更多>>

全选（0）

1.Systemic treatment of liver metastases from colorectal cancer.

机译：大肠癌肝转移的全身治疗。
- 作者：Alexander Stein;Hans-Joachim Schmoll
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第3期
2.Vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell cancer: latest results and clinical implications

机译：转移性肾细胞癌中的血管内皮生长因子受体酪氨酸激酶抑制剂：最新结果和临床意义
- 作者：Shahzeena Aslam;Tim Eisen
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第6期
3.Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects.

机译：三阴性乳腺癌的免疫治疗方法：最新研究和临床前景。
- 作者：John Stagg;Bertrand Allard
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第3期
4.Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?

机译：非小细胞肺癌的靶向治疗：到目前为止，我们取得了什么成就？
- 作者：Fadi S Farhat;Wissam Houhou
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第4期
5.The changing landscape in the treatment of metastatic castration-resistant prostate cancer

机译：转移性去势抵抗性前列腺癌的治疗方法不断变化
- 作者：El-AmmJ.;Aragon-ChingJ.B.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第1期
- Androgen deprivation therapy;
- Chemotherapy;
- Metastatic castration-resistant prostate cancer;
- Vaccine therapy;
6.Immunotherapy updates in pancreatic cancer: Are we there yet?

机译：胰腺癌的免疫疗法更新：我们到了吗？
- 作者：GunturuK.S.;RossiG.R.;SaifM.W.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第1期
- Immunotherapy;
- Pancreatic cancer;
- Vaccine;
7.A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancer.

机译：不可逆转局部晚期非小细胞肺癌的顺铂和吉西他滨诱导化疗联合顺铂和吉西他滨联合胸腔放疗的II期单臂研究。
- 作者：Peter Driesen;Marc Lambrechts;Kees Kraaij;Victoria Soldatenkova;Nadia Chouaki;Benoit Colinet
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第3期
8.Gastric cancer and trastuzumab: First biologic therapy in gastric cancer

机译：胃癌和曲妥珠单抗：胃癌的首个生物疗法
- 作者：GunturuK.S.;WooY.;BeaubierN.;RemottiH.E.;SaifM.W.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第2期
- Gastric cancer;
- Trastuzumab;
9.Bevacizumab and ovarian cancer

机译：贝伐单抗和卵巢癌
- 作者：GarciaA.;SinghH.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第2期
- Bevacizumab;
- Combination therapy;
- Ovarian cancer;
- Progression-free survival;
- Single-agent therapy;
10.Targeted approach to metastatic colorectal cancer: What comes beyond epidermal growth factor receptor antibodies and bevacizumab?

机译：转移性结直肠癌的靶向治疗方法：除了表皮生长因子受体抗体和贝伐单抗以外，还有什么？
- 作者：TroianiT.;MartinelliE.;MorgilloF.;CapassoA.;NappiA.;SforzaV.;CiardielloF.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第1期
11.Tegafur-uracil (UFT) in lower doses is safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: A proof of principle

机译：较低剂量的替加氟尿嘧啶（UFT）可安全治疗部分二氢嘧啶脱氢酶缺乏症患者的大肠癌：原理证明
- 作者：CuberoD.I.G.;DelGiglioA.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第1期
12.Detection and minimally invasive treatment of early squamous lung cancer.

机译：早期鳞癌的检测和微创治疗。
- 作者：Johannes M A Daniels;Thomas G Sutedja
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第4期
13.Targeted therapies in medical oncology: Successes, failures and next steps

机译：医学肿瘤学的靶向疗法：成功，失败和下一步
- 作者：MallarkeyG.;CoombesR.C.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第1期
14.Imaging techniques as predictive and prognostic biomarkers in renal cell carcinoma

机译：成像技术作为肾细胞癌的预测和预后生物标志物
- 作者：NathanP.;VinayanA.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第2期
- Biomarkers;
- Imaging;
- Prediction;
- Prognosis;
- Renal cell carcinoma;
15.Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients

机译：在部分二氢嘧啶脱氢酶缺乏症患者中，标准剂量替加氟尿嘧啶（UFT）不是安全的替代品
- 作者：DeenenM.J.;CatsA.;BeijnenJ.H.;SchellensJ.H.M.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第1期
16.Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.

机译：孕妇宫颈癌：治疗，等待还是中断？评估当前的临床指南，创新和争议。
- 作者：Sileny N Han;Mina Mhallem Gziri;Kristel Van Calsteren;Frédéric Amant
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2013年第4期
17.Novel agents in development for advanced non-small cell lung cancer

机译：正在开发用于晚期非小细胞肺癌的新型药物
- 作者：StinchcombeT.E.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第5期
- anaplastic lymphoma kinase;
- dacomitinib;
- epidermal growth factor receptor;
- ganetespib;
- nintedanib;
- onartuzumab;
- targeted therapy;
- tivantinib;
18.Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: Latest evidence and clinical implications

机译：早期人类表皮生长因子受体2阳性乳腺癌的新辅助治疗：最新证据和临床意义
- 作者：PernasSimonS.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第5期
- dual HER2 blockade;
- early breast cancer;
- HER2 positive;
- neoadjuvant therapy;
- pathological complete response;
- predictive biomarkers;
19.Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence.

机译：在长期维持性癌症治疗中使用抗炎/抗氧化剂：疾病进展和复发的新治疗方法。
- 作者：Sarah Crawford
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第2期
20.Treatment options in recurrent ovarian cancer: Latest evidence and clinical potential

机译：复发性卵巢癌的治疗选择：最新证据和临床潜力
- 作者：LuveroD.;MilaniA.;LedermannJ.A.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第5期
- bevacizumab;
- platinum resistant;
- platinum sensitive;
- poly-ADP ribose polymerase inhibitors;
- relapsed ovarian cancer;
21.Deciding site of biopsy at metastatic relapse

机译：转移复发时活检的决定部位
- 作者：VenniyoorA.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第6期
- Epidemiology;
- Hungary;
- Multiple sclerosis;
- Prevalence;
22.The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers

机译：乳腺癌中的PI3K / AKT / mTOR途径：靶标，试验和生物标志物
- 作者：PaplomataE.;OReganR.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第4期
23.Targeting angiogenesis in advanced cervical cancer

机译：靶向晚期宫颈癌的血管生成
- 作者：EskanderR.N.;TewariK.S.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第6期
- angiogenesis;
- bevacizumab;
- cervical cancer;
24.Tumor heterogeneity in the clinic: is it a real problem?

机译：临床肿瘤异质性：这是一个真正的问题吗？
- 作者：Filip Janku
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第2期
25.Castration-resistant prostate cancer: Latest evidence and therapeutic implications

机译：去势抵抗性前列腺癌：最新证据和治疗意义
- 作者：SuzmanD.L.;AntonarakisE.S.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第4期
- cabozantinib;
- castration-resistant prostate cancer;
- custirsen;
- radium-223 dichloride;
- tasquinimod;
26.Regorafenib in gastrointestinal stromal tumors: Clinical evidence and place in therapy

机译：瑞格非尼治疗胃肠道间质瘤的临床证据和治疗方法
- 作者：FerraroD.;ZalcbergJ.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第5期
- gastrointestinal stromal tumors;
- regorafenib;
- targeted therapies;
27.Current and future options in the management and treatment of uterine sarcoma.

机译：当前和将来子宫肉瘤的治疗和治疗选择。
- 作者：Khalid El-Khalfaoui;Andreas du Bois;Florian Heitz;Christian Kurzeder;Jalid Sehouli;Philipp Harter
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第1期
28.Taxanes: vesicants, irritants, or just irritating?

机译：紫杉烷类：起泡剂，刺激性或刺激性？
- 作者：Meagan S Barbee;Taofeek K Owonikoko;R Donald Harvey
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第1期
29.Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer

机译：放射性碘难治性分化型甲状腺癌的治疗策略
- 作者：WordenF.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第6期
- lenvatinib;
- sorafenib;
- thyroid cancer;
30.Deciding site of biopsy at metastatic relapse: Reply

机译：转移灶复发时活检的决定部位：回复
- 作者：JankuF.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第6期
31.Recent advances in the treatment of gastrointestinal stromal tumors

机译：胃肠道间质瘤治疗的最新进展
- 作者：SerranoC.;GeorgeS.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第3期
- c-KIT;
- gastrointestinal stromal tumors;
- imatinib;
- masitinib;
- nilotinib;
- regorafenib;
- sorafenib;
- sunitinib;
32.Neoadjuvant chemotherapy in advanced ovarian cancer: Latest results and place in therapy

机译：晚期卵巢癌的新辅助化疗：最新结果和治疗方法
- 作者：SatoS.;ItamochiH.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第6期
- advanced ovarian cancer;
- interval debulking surgery;
- neoadjuvant chemotherapy;
33.Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications.

机译：非小细胞肺癌诱导治疗后的维持治疗：最新证据和临床意义。
- 作者：Ryan D Gentzler;Jyoti D Patel
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第1期
34.Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: Latest evidence and clinical potential

机译：人类表皮生长因子受体2（HER2）阳性转移性乳腺癌中的Ado-曲妥珠单抗Emtansine（T-DM1）：最新证据和临床潜力
- 作者：PeddiP.F.;HurvitzS.A.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第5期
- ado-trastuzumab emtansine;
- antibody-drug conjugate;
- breast cancer;
- HER2;
- T-DM1;
35.Bone and brain metastasis in lung cancer: Recent advances in therapeutic strategies

机译：肺癌的骨和脑转移：治疗策略的最新进展
- 作者：DAntonioC.;PassaroA.;GoriB.;DelSignoreE.;MigliorinoM.R.;RicciardiS.;FulviA.;DeMarinisF.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第3期
- afatinib;
- bone;
- brain;
- epidermal growth factor;
- erlotinib;
- gefitinib;
- lung cancer;
- metastases;
36.Relapsed small cell lung cancer: treatment options and latest developments.

机译：复发性小细胞肺癌：治疗选择和最新进展。
- 作者：Nobuhiro Asai;Yoshihiro Ohkuni;Norihiro Kaneko;Etsuro Yamaguchi;Akihito Kubo
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第2期
37.Treatment of older patients with colorectal cancer: A perspective review

机译：老年结直肠癌患者的治疗：观点回顾
- 作者：KordatouZ.;KountourakisP.;PapamichaelD.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第3期
- chemotherapy;
- colorectal cancer;
- elderly;
- geriatric;
- surgical management;
38.The efficacy of second-line hormone therapy for recurrence during adjuvant hormone therapy for breast cancer.

机译：乳腺癌辅助激素治疗期间二线激素治疗复发的功效。
- 作者：Ryutaro Mori;Yasuko Nagao
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第2期
39.Isolated hepatic perfusion for patients with liver metastases

机译：肝转移患者的孤立肝灌注
- 作者：ReddyS.K.;KesmodelS.B.;AlexanderH.R.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第4期
40.Triple-negative breast cancer: Bridging the gap from cancer genomics to predictive biomarkers

机译：三阴性乳腺癌：弥合癌症基因组学与预测性生物标志物之间的鸿沟
- 作者：DavisS.L.;EckhardtS.G.;TentlerJ.J.;DiamondJ.R.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第3期
- biomarkers;
- targeted therapy;
- triple-negative breast cancer;
41.Intermittent dosing with vemurafenib in BRAF V600E-mutant melanoma: Review of a case series

机译：在BRAF V600E突变型黑素瘤中间歇给予vemurafenib：一个病例系列的回顾
- 作者：DooleyA.J.;GuptaA.;BhattacharyyaM.;MiddletonM.R.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第6期
- intermittent;
- melanoma;
- resistance;
- toxicity;
- vemurafenib;
42.Transfusions and patient burden in chemotherapy-induced anaemia in France

机译：法国化疗引起的贫血的输血和患者负担
- 作者：Corey-LisleP.K.;DesrosiersM.-P.;CollinsH.;DeLaOrdenM.;PayneK.A.;LevachéC.B.;DumontP.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2014年第4期
- anaemia;
- chemotherapy;
- patient burden;
- red blood cell transfusion;
43.Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy?

机译：经活检诊断为代谢综合症或其成分与前列腺癌有关吗？
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第2期
- metabolic syndrome;
- prostate biopsy;
- prostate cancer;
44.Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma

机译：卡培他滨联合贝伐单抗治疗转移性肝上皮样血管内皮瘤
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第4期
- bevacizumab;
- capecitabine;
- epithelioid;
- hemangioendothelioma;
- heptatic;
- metastatic;
45.Nivolumab in melanoma: Latest evidence and clinical potential

机译：黑色素瘤的Nivolumab：最新证据和临床潜力
- 作者：Vanderbilt-IngramCancerCenterVanderbiltUniversityMedicalCenter
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第2期
- anti-PD-1;
- checkpoint inhibitor;
- immunotherapy;
- melanoma;
- nivolumab;
46.Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance

机译：芳香酶抑制剂对早期乳腺癌的骨骼不良影响：迄今为止的证据和临床指导
- 作者：Servitja Sonia;Martos Tamara;Rodriguez Sanz Maria;Garcia-Giralt Natalia;Prieto-Alhambra Daniel;Garrigos Laia;Nogues Xavier;Tusquets Ignasi
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第5期
- aromatase inhibitors;
- breast cancer;
- musculoskeletal toxicity;
47.Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

机译：人类表皮生长因子受体2阳性（HER2 +）转移性乳腺癌：最新结果如何改善治疗选择
- 作者：Jiang Hanfang;Rugo Hope S.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第6期
- breast cancer;
- HER2;
- lapatinib;
- pertuzumab;
- ado-trastuzumab emtansine;
48.Anti-programmed death receptor 1 immunotherapy in melanoma: Rationale, evidence and clinical potential

机译：黑色素瘤中的抗程序性死亡受体1免疫疗法：原理，证据和临床潜力
- 作者：CutaneousOncologyMoffittCancerCenter;GraduateMedicalEducationMoffittCancerCenterTampa
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第1期
- Immunotherapy;
- Melanoma;
- Programmed death receptor 1;
- Programmed death receptor ligand;
49.Optimal management of hormone receptor positive metastatic breast cancer in 2016

机译：2016年激素受体阳性转移性乳腺癌的优化管理
- 作者：Reinert Tomas;Barrios Carlos H.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第6期
- advanced breast cancer;
- breast neoplasms;
- drug resistance;
- hormone receptor;
50.Long-term survival as a treatment benchmark in melanoma: Latest results and clinical implications

机译：长期生存作为黑色素瘤的治疗基准：最新结果和临床意义
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2015年第3期
- b-raf;
- dabrafenib;
- immunotherapy;
- ipilimumab;
- melanoma;
- nivolumab;
- pembrolizumab;
- targeted therapy;
- trametinib;
- vemurafenib;
51.Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity

机译：在转移性结直肠癌中使用贝伐单抗与不同的化疗方案：平衡效用和低毒性
- 作者：G. Chong;N. C. Tebbutt
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第5期
- bevacizumab;
- colorectal cancer;
- overall survival;
- progression-free survival;
- tolerability;
52.Advanced non-small cell lung cancer: the role of maintenance therapy

机译：晚期非小细胞肺癌：维持治疗的作用
- 作者：Anuj K. Agarwala;Nasser H. Hanna
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第1期
- maintenance therapy;
- non-small cell lung cancer;
- overall survival;
- targeted therapy;
53.Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

机译：化学疗法引起的腹泻：病理生理学，频率和基于指南的管理
- 作者：Alexander Stein;Wieland Voigt;Karin Jordan
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第1期
- chemotherapy-induced diarrhea;
- frequency;
- irinotecan;
- loperamide;
- octreotide;
- pathophysiology;
- prevention management;
54.The role of peri-operative treatment in resectable liver metastases of colorectal cancer

机译：围手术期治疗在结直肠癌可切除肝转移中的作用
- 作者：Alexander Stein;Joern Riissel;Stefan Peinert;Dirk Arnold
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第6期
- colorectal cancer;
- curative intent resection;
- liver metastases;
- peri-operative treatment;
55.Practical considerations in ovarian cancer chemotherapy

机译：卵巢癌化疗的实际考虑
- 作者：Mihaela Cristea;Ernest Han;Lennie Salmon;Robert J. Morgan;Jr
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第3期
- ovarian cancer;
- chemotherapy;
- intraperitoneal;
56.Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects

机译：高危II期或III期结肠癌的联合治疗：当前实践和未来前景
- 作者：Diogo Assed Bastos;Suilane Coelho Ribeiro;Daniela de Freitas;Paulo M. Hoff
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第4期
- adjuvant chemotherapy;
- colon cancer;
- combined therapy;
- high-risk stage II;
57.What is the role of maintenance therapy in the treatment of non-small cell lung cancer?

机译：维持疗法在非小细胞肺癌治疗中的作用是什么？
- 作者：Yixing Jiang;Taofeek K. Owonikoko;Suresh S. Ramalingam;Fadlo R. Khuri;Chandra P. Belani
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第4期
58.Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions

机译：转移性肾细胞癌的靶向治疗：当前治疗方法和未来方向
- 作者：Daniel Y.C. Heng;Christian Kollmannsberger;Kim N. Chi
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第1期
59.Renal cell carcinoma bone metastases: clinical advances

机译：肾细胞癌骨转移：临床进展
- 作者：Chakshu Sahi;Jennifer J. Knox;Mark demons;Anthony M. Joshua;Reuben Broom
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第2期
- bisphosphonates;
- bone metastases;
- bone pain scales;
- renal cell carcinoma;
- targeted therapy;
- urinary N-telopeptide;
60.Treating advanced non-small cell lung cancer in the elderly

机译：老年晚期非小细胞肺癌的治疗
- 作者：Paolo Maione;Antonio Rossi;Paola Claudia Sacco;Maria Anna Bareschino;Clorinda Schettino;Marianna Luciana Ferrara;Marzia Falanga;Rita Ambrosio;Cesare Gridelli
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第4期
- chemotherapy;
- elderly patients;
- non-small cell lung cancer;
- targeted therapies;
61.Highlights of the 2nd European Lung Cancer Conference

机译：第二届欧洲肺癌会议的要点
- 作者：Frances A. Shepherd;Gordon Maliarkey
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第5期
62.Chemotherapy in newly diagnosed primary central nervous system lymphoma

机译：新诊断的原发性中枢神经系统淋巴瘤的化疗
- 作者：Nooshin Hashemi Sadraei;David M. Peereboom
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第4期
63.Targeting angiogenesis in melanoma: prospects for the future

机译：靶向黑色素瘤中的血管生成：未来前景
- 作者：P.G. Corrie;B. Basu;K. Ahmad Zaki
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第6期
- angiogenesis;
- angiogenesis inhibitors;
- melanoma;
- treatment;
- vascular endothelial growth factor;
64.Predictive and prognostic molecular markers for cancer medicine

机译：癌症医学的预测性和预后性分子标记
- 作者：Sunali Mehta;Andrew Shelling;Anita Muthukaruppan;Annette Lasham;Cherie Blenkiron;George Laking;Cristin Print
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第2期
- biomarker;
- cancer;
- microarray;
- pathology;
- prognosis;
- treatment response;
65.Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer

机译：卵巢癌耐药性的表观遗传驱动因子的治疗性调节
- 作者：Constanze Zeller;Robert Brown
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第5期
- CpG islands;
- DNA methylation;
- drug resistance;
- epigenetics;
- histones;
- ovarian cancer;
- therapies;
66.Circulating tumour cells: their utility in cancer management and predicting outcomes

机译：循环肿瘤细胞：它们在癌症管理和预测结果中的作用
- 作者：Matthew G. Krebs;Jian Mei Hou;Tim H. Ward;Fiona H. Blackball;Caroline Dive
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第6期
67.The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations

机译：表皮生长因子受体（EGFR）抑制剂在一线治疗EGFR突变阳性的晚期非小细胞肺癌患者中的新兴作用
- 作者：Isamu Okamoto;Tetsuya Mitsudomi;Kazuhiko Nakagawa;Masahiro Fukuoka
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第5期
68.Which patients with renal cancer may benefit from sunitinib therapy?

机译：哪些肾癌患者可以从舒尼替尼治疗中受益？
- 作者：Tom Ferguson;Martin Gore
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第2期
69.Systemic therapy for metastatic pancreatic adenocarcinoma

机译：转移性胰腺腺癌的全身治疗
- 作者：Ben Lawrence;Michael Findlay
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第2期
- adenocarcinoma;
- antineoplastic agents;
- chemotherapy;
- metastatic therapeutics;
- pancreas;
- pancreatic neoplasms;
70.Targeted therapies in small cell lung cancer: a review

机译：小细胞肺癌的靶向治疗：综述
- 作者：Aidalena Z. Abidin;Marina C. Garassino;Raffaele Califano;Amelie Harle;Fiona Blackhall
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第1期
71.Thyroid cancer: emerging role for targeted therapies

机译：甲状腺癌：靶向治疗的新兴作用
- 作者：Jennifer A. Sipos;Manisha H. Shah
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第1期
- targeted therapy;
- thyroid cancer;
- tyrosine kinase inhibitors;
72.The way forward in treating pancreatic cancer Valeriy Sedov and Elizabeth Poplin

机译：胰腺癌的治疗方法Valeriy Sedov和Elizabeth Poplin
- 作者：Anonymous
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第3期
73.Updates on novel therapies for metastatic renal cell carcinoma

机译：转移性肾细胞癌新疗法的最新进展
- 作者：Kevin D. Courtney;Toni K. Choueiri
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第3期
- carcinoma;
- renal cell;
- therapeutics;
74.Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

机译：贝伐单抗在晚期乳腺癌患者中的治疗：我们在哪里着陆？
- 作者：L. Y. Dirix;P. A. Van Dam;A. M. Prove;P. B. Vermeulen
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第5期
- advanced breast cancer;
- bevacizumab;
- chemotherapy;
- vascular endothelial growth factor;
75.Latest therapeutic advances from the ASCO 2010 Annual Meeting

机译：ASCO 2010年会的最新治疗进展
- 作者：R. Charles Coombes;Gordon Maliarkey
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第6期
76.Targeting the Hedgehog pathway in cancer

机译：针对癌症中的刺猬通路
- 作者：Sachin Gupta;Naoko Takebe;Patricia LoRusso
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第4期
- basal cell carcinoma;
- cancer stem cells;
- GDC-0449;
- Hedgehog;
- medulloblastoma;
77.Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer

机译：每周5-氟尿嘧啶/亚叶酸/奥沙利铂/伊立替康在胃肠道癌一线治疗中的安全性和有效性
- 作者：Stefan Peinert;Wilfried Grothe;Alexander Stein;Lutz P. Muller;Joern Ruessel;Wieland Voigt;Hans Joachim Schmoll;Dirk Arnold
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第3期
- chemotherapy;
- clinical trial;
- colorectal cancer;
- gastric cancer;
- gastrointestinal cancer;
- 5-fluorouracil;
- irinotecan;
- oxaliplatin;
78.Redefining hormone resistance in prostate cancer

机译：重新定义前列腺癌的激素抵抗
- 作者：Christopher J. Hoimes;W. Kevin Kelly
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第2期
79.Castration-resistant prostate cancer: new science and therapeutic prospects

机译：去势抵抗性前列腺癌：新的科学和治疗前景
- 作者：Joaquim Bellmunt;William K. Oh
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第3期
- castration-resistant prostate cancer;
- chemotherapy;
- new agents;
- targeted therapies;
80.Choosing chemotherapy in patients with advanced urothelial cell cancer who are unfit to receive cisplatin-based chemotherapy

机译：不适合接受基于顺铂的化疗的晚期尿路上皮细胞癌患者的化疗选择
- 作者：F.Y.F.L de Vos;R. de Wit
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2010年第6期
- bladder cancer;
- chemotherapy;
- cisplatin;
- treatment options;
81.Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables

机译：III期非小细胞肺癌的预后因素：常规，代谢和新生物学变量的综述
- 作者：Thierry Berghmans;Marianne Paesmans;Jean Paul Sculier
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第3期
- non-small cell lung carcinoma;
- prognosis;
- stage;
- performance status;
82.Latest advances in medical oncology: highlights from Milan ESMO 2010 annual congress

机译：医学肿瘤学的最新进展：米兰ESMO 2010年度大会的要点
- 作者：Gordon Mallarkey
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第1期
83.c-MET: an exciting new target for anticancer therapy

机译：c-MET：令人激动的抗癌新靶标
- 作者：Johann S. de Bono;Timothy A. Yap
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第1期
84.Future directions in the evaluation of c-MET-driven malignancies

机译：评估c-MET驱动的恶性肿瘤的未来方向
- 作者：Johann S. de Bono;Timothy A. Yap
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第1期
- c-MET;
- drug development;
- targeted therapy;
- treatment resistance;
- patient selection;
- biomarkers;
85.Denosumab for the treatment of bone metastases in breast cancer: Evidence and opinion

机译：地诺单抗治疗乳腺癌骨转移的证据和意见
- 作者：StegerG.G.;BartschR.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第5期
86.How close are we to customizing chemotherapy in early non-small cell lung cancer?

机译：我们离早期非小细胞肺癌的定制化疗有多近？
- 作者：Georgios loannidis;Vassilis Georgoulias;John Souglakos
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第4期
- non-small cell lung cancer;
- adjuvant therapy;
- neoadjuvant therapy;
- biomarkers;
- individualized therapy;
87.Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer

机译：一线和后继系统治疗非小细胞肺癌的经验
- 作者：B. K. Eccles;T. R. Geldart;V. M. Laurence;K. L. Bradley;M. T. Lwin
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第4期
- non-small cell lung cancer;
- retrospective analysis;
- systemic therapy;
88.Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities

机译：非小细胞肺癌的基因型驱动疗法：关注EGFR，KRAS和ALK基因异常
- 作者：Elizabeth M. Gaughan;Daniel B. Costa
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第3期
- ALK;
- ALK inhibitor;
- EGFR;
- EGFR inhibitor;
- KRAS;
- lung cancer;
- metastasis;
- mutation;
- non-small cell lung cancer;
89.Preventing bowel cancer: an insight for clinicians

机译：预防肠癌：临床医生的见解
- 作者：Andrew R. Hart;Hugh J. Kennedy
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第6期
- colorectal cancer;
- prevention;
90.The potential for crizotinib in non-small cell lung cancer: a perspective review

机译：克唑替尼在非小细胞肺癌中的潜力：前景回顾
- 作者：Yung Jue Bang
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第6期
- anaplastic lymphoma kinase;
- carcinoma;
- crizotinib;
- non-small cell lung cancer;
- tyrosine kinase inhibitor;
91.Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective

机译：重新评估不可切除的转移性结直肠癌的原发肿瘤手术的必要性：概述和观点
- 作者：George A. Poultsides;Phillip B. Paty
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第1期
- chemotherapy;
- colorectal cancer;
- primary tumor;
- stage IV;
92.Balancing the efficacy and toxicity of chemotherapy in colorectal cancer

机译：平衡大肠癌化疗的疗效和毒性
- 作者：Michael S. Braun;Matthew T. Seymour
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第1期
- colorectal cancer;
- combination chemotherapy;
- fluorouracil;
- irinotecan;
- oxaliplatin;
- performance status;
- staged chemotherapy;
- toxicity;
- treatment breaks;
93.Therapeutic options in cutaneous melanoma: Latest developments

机译：皮肤黑素瘤的治疗选择：最新进展
- 作者：AmariaR.N.;LewisK.D.;GonzalezR.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第5期
- BRAF mutation;
- Ipilimumab;
- Metastatic melanoma;
- Targeted therapy;
- Vemurafenib;
94.The role of the c-Met pathway in lung cancer and the potential for targeted therapy

机译：c-Met途径在肺癌中的作用和靶向治疗的潜力
- 作者：Martin Sattler;Rifat Hasina;Mamatha M. Reddy;Tara Gangadhar;Ravi Salgia
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第4期
- hepatocyte growth factor;
- kinase inhibitors;
- MET;
- targeted therapy;
95.Maintenance therapy in advanced non-small cell lung cancer: evolution, tolerability and outcomes

机译：晚期非小细胞肺癌的维持治疗：进展，耐受性和结果
- 作者：Linda E. Coate;Frances A. Shepherd
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第3期
- anti-angiogenic;
- cetuximab;
- chemotherapy;
- erlotinib;
- gefitinib;
- maintenance;
- non-small cell lung cancer;
- prolonged;
96.Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists

机译：妊娠期乳腺癌的化学疗法：肿瘤学家的证据和指南
- 作者：Sophie E. McGrath;Alistair Ring
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第2期
- breast cancer;
- chemotherapy;
- pregnancy;
97.Customizing systemic therapy in patients with advanced non-small cell lung cancer

机译：定制晚期非小细胞肺癌患者的全身治疗
- 作者：A. M. Sadowska;V. Nowe;A. Janssens;E. Boeykens;W. A. De Backer;P. R. Germonpre
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第4期
- bevacizumab;
- histology;
- non-small cell lung cancer;
- pemetrexed;
- personalized therapy;
- tyrosine kinase inhibitors;
98.Advancing breast cancer therapy by translational research: Highlights of the Improving Care and Knowledge through Translational Research (IMPAKT) breast cancer conference

机译：通过转化研究促进乳腺癌治疗：通过转化研究（IMPAKT）乳腺癌会议改善护理和知识的重点
- 作者：MallarkeyG.;CharlesCoombesR.
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第5期
99.The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy

机译：聚（ADP-核糖）聚合酶抑制剂在癌症治疗中的潜力
- 作者：M. Javle;N. J. Curtin
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第6期
- BRCA2 gene;
- DNA repair-deficiency disorders;
- poly (ADP-ribose) polymerases;
100.Bevacizumab in metastatic breast cancer: when may it be used?

机译：贝伐单抗治疗转移性乳腺癌：什么时候可以使用？
- 作者：Shari B. Goldfarb;Clifford Hudis;Maura N. Dickler
- 期刊名称：《Therapeutic advances in medical oncology.》 | 2011年第2期
- bevacizumab;
- breast cancer;
- progression-free survival;
- vascular endothelial growth factor;

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号